GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Alembic Pharmaceuticals APLLTD.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

1,017.30

+5.40%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2026

Revenue

₹73.45bn

FY2017FY2026

Net income

₹6.75bn

FY2017FY2026

Free cash flow

₹2.61bn

FY2017FY2026

Shareholders' equity

₹56.75bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue₹73.45bn₹66.72bn₹62.29bn₹56.53bn₹53.06bn₹53.93bn₹46.06bn₹39.35bn₹31.30bn₹31.05bn
Research and development₹378.3m₹5.22bn₹4.75bn₹7.22bn₹8.38bn₹6.70bn₹6.45bn₹5.04bn₹4.11bn₹4.27bn
Operating income₹8.00bn₹7.86bn₹6.88bn₹4.38bn₹6.43bn₹23.32bn₹19.86bn₹7.56bn₹5.36bn₹5.38bn
Net income₹6.75bn₹5.83bn₹6.16bn₹3.42bn₹5.21bn₹11.46bn₹8.29bn₹5.84bn₹4.13bn₹4.03bn
Diluted earnings per share34.3329.6831.1917.4026.4958.3642.1530.9921.8921.39

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets₹87.63bn₹77.73bn₹64.46bn₹61.83bn₹71.22bn₹67.09bn₹59.89bn₹47.78bn₹39.41bn₹26.87bn
Cash and short-term investments₹2.03bn₹901.0m₹1.20bn₹754.8m₹610.9m₹2.85bn₹718.4m₹1.99bn₹959.3m₹1.53bn
Total liabilities₹30.94bn₹25.83bn₹16.27bn₹18.12bn₹18.84bn₹16.42bn₹27.99bn₹20.60bn₹17.21bn₹7.85bn
Debt₹14.30bn₹12.57bn₹5.13bn₹7.22bn₹7.17bn₹5.84bn₹18.31bn₹11.28bn₹7.08bn₹885.2m
Shareholders' equity₹56.75bn₹51.91bn₹48.18bn₹43.70bn₹52.38bn₹50.67bn₹32.19bn₹27.19bn₹22.20bn₹19.01bn
Shares outstanding197m197m197m197m197m196m197m189m188m188m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations₹6.95bn₹879.7m₹8.03bn₹7.24bn₹5.52bn₹14.63bn₹4.49bn₹8.12bn₹3.12bn₹2.89bn
Capital spending−₹4.35bn−₹5.64bn−₹3.27bn−₹4.43bn−₹4.26bn−₹6.60bn−₹7.35bn−₹7.64bn−₹8.22bn−₹4.70bn
Free cash flow₹2.61bn−₹4.76bn₹4.76bn₹2.81bn₹1.27bn₹8.04bn−₹2.86bn₹475.9m−₹5.09bn−₹1.82bn
Dividends paid−₹2.16bn−₹2.16bn−₹1.57bn−₹1.97bn−₹2.75bn−₹2.75bn−₹3.26bn−₹909.1m−₹907.6m−₹901.0m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₹21.50bn₹18.48bn₹18.76bn₹19.10bn₹17.11bn₹17.70bn₹16.93bn₹16.48bn
Operating income₹2.34bn₹1.39bn₹2.13bn₹2.40bn₹8.81bn₹2.31bn₹8.56bn₹8.27bn
Net income₹1.73bn₹2.03bn₹1.33bn₹1.85bn₹1.54bn₹1.57bn₹1.38bn₹1.53bn
Diluted earnings per share8.8010.316.769.407.857.987.017.77
Cash from operations———₹4.03bn—₹879.0m—−₹1.01bn
Capital spending———−₹2.34bn—−₹5.64bn—−₹1.90bn
Free cash flow———₹1.69bn—−₹4.76bn—−₹2.91bn
Total assets—₹87.63bn—₹83.97bn—₹77.73bn—₹72.30bn
Cash and short-term investments₹1.96bn₹2.03bn₹1.43bn₹1.55bn₹834.8m₹901.0m₹1.29bn₹1.49bn
Debt—₹13.85bn—₹14.89bn—₹12.57bn—₹10.66bn
Shareholders' equity₹56.69bn₹56.75bn₹53.16bn₹53.19bn₹51.90bn₹51.91bn₹48.88bn₹48.88bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue9.1%6.4%8.9%
Operating income22.3%-19.3%-6.4%
Net income25.4%-10.1%-0.6%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin11.3%10.5%15.5%20.3%
Net margin9.0%8.6%10.6%12.5%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings26.828.534.243.621.613.724.518.427.424.8
Price to sales2.52.53.42.62.12.94.42.73.63.2

Dividends and splits

Per share, in the currency the company pays

Paid for 14 years. Last went ex-dividend on 29 Jul 2026.

FY2027FY2026FY2025FY2024FY2023FY2022FY2020FY2019
Paid in the year12.0011.0011.008.0010.0014.0012.504.00

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.